electronRx pairs a smartphone-based measurement returning respiratory function in around sixty seconds backed by a 644-subject investigation across the UK and Japan with a platform architected for multiple chronic conditions.

Building Regulatory-Ready Digital Insights for Respiratory Care. electronRx delivers clinically-validated digital solutions for the real-time monitoring, management, and diagnosis of patients with COPD, Asthma, Interstitial Lung Disease and Pulmonary Hypertension. Our platform transforms respiratory drug development and commercialisation by enabling: ✅ Digital biomarkers to support clinical endpoints ✅ Remote phenotyping and patient stratification ✅ Real-world data for evidence generation ✅ Companion tools that improve engagement and outcomes We partner with pharmaceutical leaders to advance trials, uncover insights beyond the clinic, and enhance treatment impact across the respiratory pipeline.